Anzeige
Mehr »
Freitag, 05.12.2025 - Börsentäglich über 12.000 News
Das Timing könnte nicht besser sein - Durchbruchsjahr 2026 für Myriad
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NEYG | ISIN: US30211M1036 | Ticker-Symbol: N/A
1-Jahres-Chart
EXOUSIA ADVANCED MATERIALS INC Chart 1 Jahr
5-Tage-Chart
EXOUSIA ADVANCED MATERIALS INC 5-Tage-Chart

Aktuelle News zur EXOUSIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17:02Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement172ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced...
► Artikel lesen
DoRenowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview1
EXOUSIA Aktie jetzt für 0€ handeln
DiExousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms321ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the...
► Artikel lesen
DiExousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.191EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as...
► Artikel lesen
17.11.Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value324ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it...
► Artikel lesen
04.11.Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery385Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused...
► Artikel lesen
28.10.Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA323Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)...
► Artikel lesen
29.09.Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes314ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan...
► Artikel lesen
26.09.Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding323Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company...
► Artikel lesen
10.09.Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets273ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic...
► Artikel lesen
08.09.Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division384Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025...
► Artikel lesen
03.09.Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions357Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion...
► Artikel lesen
25.06.Marijuana Inc.: Exousia Pro Files Reg A.260ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of...
► Artikel lesen
18.06.Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board585Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company...
► Artikel lesen
30.04.Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant298Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage...
► Artikel lesen
29.04.Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application321- Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based...
► Artikel lesen
21.04.Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview387A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,...
► Artikel lesen
17.04.Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions380ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is...
► Artikel lesen
08.04.Marijuana Inc.: Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show414Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company...
► Artikel lesen
03.04.Marijuana Inc.: Exousia Pro Issues Update on Name Change283ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1